[Asia Economy Reporter Minji Lee] ST Pharm announced on the 23rd that it recorded an operating loss of 4.872 billion KRW in the second quarter, continuing its deficit compared to the previous quarter. Sales increased by 67% from the previous quarter to 33.776 billion KRW, and net profit turned positive during the same period, recording 1.739 billion KRW.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing